Yasho Industries Limited (NSE:YASHO) filed the transcript of its Q1 FY27 earnings conference call with the exchanges on 10 August 2026. The call, held on 3 August 2026, reported consolidated revenue of Rs. 308 crores and an EBITDA margin of 24.2% for the quarter ended June 30, 2026.
Key Highlights
- Yasho Industries posted its highest-ever quarterly consolidated revenue of Rs. 308 crores in Q1 FY27, reflecting a 42% year-on-year volume increase.
- EBITDA for the quarter stood at Rs. 74.42 crores, translating to an EBITDA margin of 24.2%, up from 17% in the prior comparable period.
- Profit after tax for Q1 FY27 was Rs. 36 crores, representing a PAT margin of 11.7%; both CRISIL and ICRA upgraded bank loan ratings from BBB+ to A-.
- The company doubled its FY27 capital expenditure plan to Rs. 250 crores from Rs. 125 crores, with approximately Rs. 100 crores to be raised through borrowings during FY27.
About the Company
Yasho Industries Limited (NSE:YASHO), headquartered in Andheri West, Mumbai, is a specialty chemicals manufacturer operating primarily in industrial chemicals, aroma chemicals, and lubricant additives. The company operates manufacturing facilities at Pakhajan and markets its products across more than 35 countries, with exports contributing a significant share of total revenue.
Announcement in Detail
During the call, Managing Director and CEO Parag Jhaveri disclosed that the company achieved consolidated revenue of Rs. 308 crores in Q1 FY27, driven by volume growth of 42% year-on-year and improved capacity utilization, which crossed 65% at its facilities. Industrial chemicals contributed nearly 89% of total revenue, while exports accounted for approximately 69%. The net debt-to-EBITDA ratio improved significantly to 1.86x as of 30 June 2026, compared with 3.75x at the close of Q4 FY26.
CFO Chirag Shah confirmed that working capital days improved from 190 days to 143 days during the quarter. Capital expenditure of Rs. 18.73 crores was incurred in Q1 FY27 towards ongoing Pakhajan plant expansion. The company revised its FY28 revenue target upward to more than Rs. 1,600 crores and guided for 30% to 40% annual revenue growth over the next few years, attributing confidence to long-term customer commitments and an R&D team of more than 50 scientists.
Impact on Investors
The filing shows a material improvement across key financial metrics in a single quarter. Investors will note that the credit rating upgrade from BBB+ to A- by both CRISIL and ICRA lowers the company's cost of future borrowings, which is relevant given the planned Rs. 100 crores of fresh debt to fund FY27 capital expenditure. The increase in capital expenditure from Rs. 125 crores to Rs. 250 crores for FY27 also signals elevated near-term leverage, which shareholders will observe when monitoring the net debt position over subsequent quarters.
The disclosed FY28 revenue target of more than Rs. 1,600 crores and margin guidance are attributed to management as forward-looking statements and are not guarantees of performance, as noted in the call's own disclaimer.
Sector / Market Context
India's specialty chemicals sector has drawn sustained global interest as multinational buyers seek supply-chain diversification. According to FICCI estimates, India's specialty chemicals market is targeted to reach USD 64 billion by 2025, with exports forming a growing component. Yasho's rising export share of approximately 69% reflects the broader trend of Indian manufacturers deepening international customer relationships.